Day Two: Thursday April 25, 2019

REGISTRATION & COFFEE

8:00

Biomarkers & Companion Diagnostics

8:30

Exploratory Biomarkers in Breast Cancer R&D

Petar Jelinic

Director, Oncology Translational Science and Clinical Biomarkers

 

Merck

9:00

Liquid Biopsies Enabling Precision Medicine

 

Jonathan Beer

Director, Lead of Disruptive Technologies

 

Novartis

9:30

Examining the factors impacting concordance of plasma testing by next generation sequencing

 

Dan Stetson

Associate Principal Scientist

 

AstraZeneca

10:00



TBC: In-Vitro Diagnostics Provider

Business Development Manager

Companion Diagnostics Co-Development

MORNING REFRESHMENTS & SPEED NETWORKING

10:30

11:30

Targeting somatic HER2 mutations in metastatic breast cancer: results from the phase II SUMMIT ‘basket’ trial

 

Al Lalani

Senior Vice President, Translational Medicine & Diagnostics

Puma Biotechnology

12:00

NKTR-214 plus NKTR-262, a Clinical Combination to Harness the Innate and the Adaptive Immune System

 

Fiore Cattaruzza

Senior Scientist - Translational Medicine

 

Nektar

LUNCH & NETWORKING

12:30

PANEL DISCUSSION

1:30

Participating:

Participants to be announced..

Novel Approaches in Breast Cancer Drug R&D

2:00

B-cell profiling from patients to discern novel public targets for breast cancer therapeutics

 

Amy Manning-Bog

Senior Director, Translational Sciences

 

Atreca

2:30

Theranostic applications in breast cancer

 

Christopher Adams

CEO

 

Andarix

AFTERNOON REFRESHMENTS & NETWORKING

3:00

3:30

Delivering an Rx/Dx solution for TNBC by targeting RSK2


Sandi Dunn

CEO

 

Phoenix Molecular

4:00

Crossing the Blood Brain Barrier: xB3 Peptide Enables Brain Penetration of Trastuzumab for the Treatment of HER2+ Breast Cancer Brain Metastases


Caroline Clairmont

Senior Vice President, R&D Operations

 

Bioasis

4:30

Plinabulin, a Novel agent for CIN: Application in Breast Cancer.


Ramon Mohanlal

EVP R&D and CMO

 

BeyondSpring

5:00

A Twenty-First Century Approach: From Primary Prevention to Intraductal Immunotherapy


Steven Quay

CEO

 

Atossa Genetics

SUMMARY & CLOSE OF CONFERENCE

5:30

VIEW PREVIOUS DAY

DOWNLOAD EVENT GUIDE

Complete the form below to download the PDF

NEO SYNTH International House, 24 Holborn Viaduct, London EC1A 2BN

contact@neo-synth.com

(+1) 617.500.5172

Submitting Form...

The server encountered an error.

Request received. Please allow some time for processing - You will receive a manual response within a few hours.

Your details will not be shared with a third party

Copyright © 2016 | All content produced by: neo-synth ltd.

Participants to be announced..

Registration

Biomarkers & Companion Diagnostics

Networking Break

Lunch

Panel Discussion

Novel Approaches

Networking Break

Close of Event

DOWNLOAD GUIDE